๐Lack of Incentive to Discover the Full Range of Applications for Off-Patent Treatments
There are roughly 10,000 known diseases afflicting humans, most of which (approximately 95%) are classified as โorphanโ (rare) diseases. The current system requires that a pharmaceutical company predict a particular condition in advance of running clinical trials. If a drug is found to be effective for other diseases after the patent has expired, no one has the financial incentive to get it approved for another disease.
Last updated